National Health (Commonwealth Price - Pharmaceutical benefits supplied by private hospitals) Determination 2020 (PB 99 of 2020)
9Dispensed price—general
Start here
Get a plain-English read of 9
Turn the raw legal text into a practical explanation grounded in National Health (Commonwealth Price - Pharmaceutical benefits supplied by private hospitals) Determination 2020 (PB 99 of 2020).
9 Dispensed price—general
(1) The dispensed price for the supply of a ready‑prepared pharmaceutical benefit by an approved hospital authority to a patient receiving treatment in or at a private hospital for which the authority is approved is: (a) if a quantity of the benefit that is ordered and supplied is equal to a multiple of a pack quantity of the benefit—the sum of: (i) for each pack quantity: (A) the approved ex‑manufacturer price or the proportional ex‑manufacturer price (as applicable) for the pack quantity; and (B) the storage and handling mark‑up under section 10 for the pack quantity; and (C) the mark‑up, worked out under section 11; and (ii) a ready‑prepared dispensing fee; and (iii) if a dangerous drug fee applies, the dangerous drug fee; or (b) if a quantity of the benefit that is ordered and supplied is less than a pack quantity of the benefit—the sum of: (i) the amount worked out under section 13; and (ii) a ready‑prepared dispensing fee; and (iii) if a dangerous drug fee applies, the dangerous drug fee; and (iv) an amount for the supply of a container, worked out under section 12; or (c) if a quantity of the benefit that is ordered and supplied is more than a multiple of a pack quantity of the benefit—the sum of: (i) for each pack quantity: (A) the approved ex‑manufacturer price or the proportional ex‑manufacturer price (as applicable) for the pack quantity; and (B) the storage and handling mark‑up under section 10 for the pack quantity; and (C) the mark‑up worked out under section 11; and (ii) for the remainder of the quantity that is less than a pack quantity—the amount worked out under section 13; and (iii) a ready‑prepared dispensing fee; and (iv) if a dangerous drug fee applies, the dangerous drug fee. (2) However, for a ready‑prepared pharmaceutical benefit that comprises the admixture of ready‑prepared ingredients and is specified in Schedule 1 to the National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Determination 2019: (a) the ready‑prepared dispensing fee does not apply; and (b) an extemporaneously‑prepared dispensing fee must be paid by the Commonwealth; and (c) no amount for the supply of the container is payable; and (d) if a dangerous drug fee applies, the dangerous drug fee.